Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment

by Hurst, Helen C
Published 2001

A Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mor...

by Bhargava, Ramya, Kalra, Philip A., Brenchley, Paul, Hurst, Helen, Hutchison, Alastair
Published 2015

Alternative TFAP2A isoforms have distinct activities in breast cancer

by Berlato, Chiara, Chan, KaYi V, Price, Anna M, Canosa, Monica, Scibetta, Angelo G, Hurst, Helen C
Published 2011

Functional Analysis of a Breast Cancer-Associated FGFR2 Single Nucleotide Polymorphism Using Zinc Finger Mediated Genome Editing

by Robbez-Masson, Luisa J., Bödör, Csaba, Jones, J. Louise, Hurst, Helen C., Fitzgibbon, Jude, Hart, Ian R., Grose, Richard P.
Published 2013

Encapsulating peritoneal sclerosis following renal transplantation despite tamoxifen and immunosuppressive therapy

by de Freitas, Declan, Augustine, Titus, Hurst, Helen, Taylor, Paul, Williams, Rosalind, Hutchison, Alastair, Brenchley, Paul E. C., Summers, Angela M.
Published 2008